Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Tumor fibroblast-derived epiregulin promotes growth of colitis-associated neoplasms through ERK
Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer
Tumor-associated Stromal Cells Expressing E-prostanoid 2 or 3 Receptors in Prostate Cancer: Correlation With Tumor Aggressiveness and Outcome by Angiogenesis and Lymphangiogenesis
Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma
Tumour expression of bladder cancer-associated urinary proteins
Tumor-targeted chemotherapy with the nanopolymer-based drug NC-6004 for oral squamous cell carcinoma
Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma
Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies
Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer
Tumor Antigen-Specific Monoclonal Antibodies and Induction of T-Cell Immunity
Tumor Heterogeneity Is Fundamental to the Tumor Ecosystem
Tumor necrosis factor haplotype diversity in Mestizo and Native populations of Mexico
Tumors exposed to acute cyclic hypoxia show increased vessel density and delayed blood supply
Tumor-line specific causes of intertumor heterogeneity in blood supply in human melanoma xenografts
Tumor Burden Talks in Cancer Treatment with PEGylated Liposomal Drugs
Tumor Necrosis Factor Receptor Type I Expression of CD4+T Cells in Rheumatoid Arthritis Enables Them to Follow Tumor Necrosis Factor Gradients Into the Rheumatoid Synovium
Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses
Tumour repopulation and the role of abortive division in squamous cell carcinomas during chemotherapy
Tumour-infiltrating CD8+lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
Tumorigenic Effects of Endocrine-disrupting Chemicals are Alleviated by Licorice (Glycyrrhiza glabra) Root Extract through Suppression of AhR Expression in Mammalian Cells
Tumour-associated mutations of PA-TM-RING ubiquitin ligases RNF167/RNF13 identify the PA domain as a determinant for endosomal localization
Tumour necrosis factor receptor 1 and mortality in a multi-ethnic cohort: the Northern Manhattan Study
Tumour immunology
Tumor rupture as an initial manifestation of malignant mesonephric mixed tumor: a case report and review of the literature
Tumor Mismatch Repair Immunohistochemistry and DNA MLH1 Methylation Testing of Patients With Endometrial Cancer Diagnosed at Age Younger Than 60 Years Optimizes Triage for Population-Level Germline Mismatch Repair Gene Mutation Testing
Tumour-stroma interactions in pancreatic ductal adenocarcinoma: Rationale and current evidence for new therapeutic strategies
Tumor size does not predict pathological complete response rates after pre-operative chemoradiotherapy for non-small cell lung cancer
Tumor Vessel Normalization by Chloroquine Independent of Autophagy
Tumor Suppressor p53 Inhibits Systemic Autoimmune Diseases by Inducing Regulatory T Cells
Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the National Swedish Kidney Cancer Register
Tumor rupture during surgery for gastrointestinal stromal tumors: Pay attention!
Tumour heterogeneity and cancer cell plasticity
Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair
Tumor surveillance by circulating microRNAs: a hypothesis
Tumor and its microenvironment: A synergistic interplay
Tumours associated with BAP1 mutations
Tumor Necrosis Factor-Alpha Induced by Hepatitis B Virus Core Mediating the Immune Response for Hepatitis B Viral Clearance in Mice Model
Tumor characteristics of breast cancer in predicting axillary lymph node metastasis
Tumor Suppressor microRNAs, miR-100 and-125b, Are Regulated by 1,25-dihydroxyvitamin D in Primary Prostate Cells and in Patient Tissue
Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells
Tumoral presence of human cytomegalovirus is associated with shorter disease-free survival in elderly patients with colorectal cancer and higher levels of intratumoral interleukin-17
Tumors and metastases of the upper cervical spine (C0-2). A special challenge
Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer
Tumor Necrosis Factor Inhibition in Severe Sepsis: A Promise Not Fulfilled
Tumor Stage After Neoadjuvant Chemotherapy Determines Survival After Surgery for Adenocarcinoma of the Esophagus and Esophagogastric Junction
Tumor-Induced Osteoclast miRNA Changes as Regulators and Biomarkers of Osteolytic Bone Metastasis
Tumor-Targeted Prodrug ICT2588 Demonstrates Therapeutic Activity against Solid Tumors and Reduced Potential for Cardiovascular Toxicity
Tumor Necrosis Factor Inhibition Modulates Thrombospondin-1 Expression in Human Inflammatory Joint Disease through Altered NR4A2 Activity
Tumor angiogenesis is caused by single melanoma cells in a manner dependent on reactive oxygen species and NF-kappa B
Tumor Heterogeneity Makes AML a "Moving Target" for Detection of Residual Disease
Tumor Necrosis Factor-related Apoptosis-inducing Ligand ( TRAIL) Signaling and Cell Death in the Immature Central Nervous System after Hypoxia-Ischemia and Inflammation
Tumor Endoprosthesis Revision Rates Increase With Peri-Operative Chemotherapy But Are Reduced With the Use of Cemented Implant Fixation
Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion
Tumor Dormancy and the Angiogenic Switch: Possible Implications of Bone Marrow-Derived Cells
Tumor Suppressor MicroRNA-27a in Colorectal Carcinogenesis and Progression by Targeting SGPP1 and Smad2
Tumour heterogeneity and immune-modulation
Tumor detection in automated breast ultrasound images using quantitative tissue clustering
Tumor LINE-1 Methylation Level and Microsatellite Instability in Relation to Colorectal Cancer Prognosis Response
Tumor-Associated Macrophages Promote Oral Cancer Progression Through Activation of the Axl Signaling Pathway
Tumour-like phenotypes in urothelial cells after exposure to antigens from eggs of Schistosoma haematobium: An oestrogen-DNA adducts mediated pathway?
Tumor Necrosis Factor alpha Is Associated With Viral Control and Early Disease Progression in Patients With HIV Type 1 Infection
Tumour size is related to the curability of signet ring cell early gastric cancer with endoscopic submucosal dissection: A retrospective single centre study
Tumor necrosis factor receptor-II nt587 polymorphism in Chinese Han patients with ankylosing spondylitis
Tumor cells forming sinusoids connected to vasculature are involved in hemorrhage of pineal choriocarcinoma
Tumor Endothelial Cell-Specific Drug Delivery System Using Apelin-Conjugated Liposomes
Tumor Marker Score for Prognostication of Early-stage Squamous Cell Cervical Cancer
Tumor lysis syndrome and malignant melanoma
Tumor Marker Carbohydrate Antigen 125 Predicts Adverse Outcome After Transcatheter Aortic Valve Implantation
Tumour necrosis factor-308 and-238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients
Tumorlike Cardiac Fungal Mycetoma Caused by Scedosporium apiospermum Presenting as Symptomatic Ventricular Tachycardia
Tumour Markers in Peritoneal Washing Fluid - Contribution to Cytology
Tumor Suppressors Status in Cancer Cell Line Encyclopedia
Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma
Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma
Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing?
Tumor volume successively reflects the state of disease progression in endometrial cancer
Tumor suppressors: enhancers or suppressors of regeneration?
Tumor suppressor gene p16/INK4A/CDKN2A-dependent regulation into and out of the cell cycle in a spontaneous canine model of breast cancer
Tumour diploidy and survival in breast cancer patients with BRCA2 mutations
Tumor necrosis factor-alpha enhances RANKL expression in gingival epithelial cells via protein kinase A signaling
Tumor suppressor p53 induces miR-1915 processing to inhibit Bcl-2 in the apoptotic response to DNA damage